Buy or sell Route 92 Medical stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Route 92 Medical Stock

Route 92 Medical is a medical device company developing a catheter to treat stroke.

About Route 92 Medical Stock

Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California.

Funding History

May 2016$5.9M
May 2017$5.9M
August 2018$4.7M
May 2019$13.0M
December 2021$56.0M
December 2021$55.0M

Management

Sr. VP Clinical, Regulatory and Quality

Kirsten Valley

Board Member

Ariella Golomb

Chief Medical Officer and Co-Founder

Joey English

General Partner @ The Vertical Group

Jack W. Lasersohn

Board Observer

Robert Mittendorff

Founder and CEO

Tony M. Chou

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo